Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Anasetti

Showing results (51-60 of 223) with videos related to

Pageof 23
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 20, 2016
Identification of DPB1 Permissive Unrelated Donors Is Highly LikelyKevin Tram, Gretta Stritesky, Kim Wadsworth, et al.
Journal of Leukocyte Biology|September 27, 2013
STAT5 polarization promotes iTregs and suppresses human T-cell alloresponses while preserving CTL capacityBrian C Betts, Anandharaman Veerapathran, Joseph Pidala, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 29, 2011
Variation in management of immune suppression after allogeneic hematopoietic cell transplantationJoseph Pidala, Stephanie J Lee, Gwen Quinn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 16, 2012
LBH589 enhances T cell activation in vivo and accelerates graft-versus-host disease in miceDapeng Wang, Cristina Iclozan, Chen Liu, et al.
American Journal of Blood Research|March 21, 2012
Bim is required for T-cell allogeneic responses and graft-versus-host disease in vivoYu Yu, Jing Yu, Cristina Iclozan, et al.
Blood|January 20, 2011
Strong CD28 costimulation suppresses induction of regulatory T cells from naive precursors through Lck signalingKenrick Semple, Antony Nguyen, Yu Yu, et al.
Journal for Immunotherapy of Cancer|May 21, 2015
Survivin-specific CD4+ T cells are decreased in patients with survivin-positive myelomaFrederick L Locke, Meghan Menges, Anandharaman Veerapathran, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 20, 2009
Biomarkers to discern transplantation tolerance after allogeneic hematopoietic cell transplantationJoseph Pidala, Gregory C Bloom, Steven Enkemann, et al.
Journal of Immunology Research and Therapy|October 11, 2016
Regulatory T-Cell Therapy for Graft-versus-host DiseaseJessica Heinrichs, David Bastian, Anandharaman Veerapathran, et al.
Haematologica|July 28, 2011
The global severity of chronic graft-versus-host disease, determined by National Institutes of Health consensus criteria, is associated with overall survival and non-relapse mortalityJoseph Pidala, Jongphil Kim, Claudio Anasetti, et al.
Pageof 23

Showing results (51-60 of 223) with videos related to

Sort By:
Pageof 23
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 20, 2016
Identification of DPB1 Permissive Unrelated Donors Is Highly LikelyKevin Tram, Gretta Stritesky, Kim Wadsworth, et al.
Journal of Leukocyte Biology|September 27, 2013
STAT5 polarization promotes iTregs and suppresses human T-cell alloresponses while preserving CTL capacityBrian C Betts, Anandharaman Veerapathran, Joseph Pidala, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 29, 2011
Variation in management of immune suppression after allogeneic hematopoietic cell transplantationJoseph Pidala, Stephanie J Lee, Gwen Quinn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 16, 2012
LBH589 enhances T cell activation in vivo and accelerates graft-versus-host disease in miceDapeng Wang, Cristina Iclozan, Chen Liu, et al.
American Journal of Blood Research|March 21, 2012
Bim is required for T-cell allogeneic responses and graft-versus-host disease in vivoYu Yu, Jing Yu, Cristina Iclozan, et al.
Blood|January 20, 2011
Strong CD28 costimulation suppresses induction of regulatory T cells from naive precursors through Lck signalingKenrick Semple, Antony Nguyen, Yu Yu, et al.
Journal for Immunotherapy of Cancer|May 21, 2015
Survivin-specific CD4+ T cells are decreased in patients with survivin-positive myelomaFrederick L Locke, Meghan Menges, Anandharaman Veerapathran, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 20, 2009
Biomarkers to discern transplantation tolerance after allogeneic hematopoietic cell transplantationJoseph Pidala, Gregory C Bloom, Steven Enkemann, et al.
Journal of Immunology Research and Therapy|October 11, 2016
Regulatory T-Cell Therapy for Graft-versus-host DiseaseJessica Heinrichs, David Bastian, Anandharaman Veerapathran, et al.
Haematologica|July 28, 2011
The global severity of chronic graft-versus-host disease, determined by National Institutes of Health consensus criteria, is associated with overall survival and non-relapse mortalityJoseph Pidala, Jongphil Kim, Claudio Anasetti, et al.
Pageof 23